| Literature DB >> 25343838 |
Sanjeev Noel1, Maria N Martina-Lingua, Samatha Bandapalle, Jennifer Pluznick, Abdel Rahim A Hamad, Daniel A Peterson, Hamid Rabb.
Abstract
The pathophysiology of acute kidney injury (AKI) involves multiple and overlapping immunological, biochemical, and hemodynamic mechanisms that modulate the effects of both the initial insult and the subsequent repair. Limited but recent experimental data have revealed that the intestinal microbiota significantly affects outcomes in AKI. Additional evidence shows significant changes in the intestinal microbiota in chronic kidney disease patients and in experimental AKI. In this minireview, we discuss the current status of the effect of intestinal microbiota on kidney diseases, the immunomodulatory effects of intestinal microbiota, and the potential mechanisms by which microbiota can modify kidney diseases and vice versa. We also propose future studies to clarify the role of intestinal microbiota in kidney diseases and to explore how the modification of gut microbiota may be a potential therapeutic tool. 2014 S. Karger AG, Basel.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25343838 PMCID: PMC4985236 DOI: 10.1159/000363209
Source DB: PubMed Journal: Nephron Clin Pract ISSN: 1660-2110